MEDEZRIN LTD.

Company Registration Number:
03340737 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

MEDEZRIN LTD.

Contents of the Financial Statements

for the Period Ended 31 March 2023

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

MEDEZRIN LTD.

Company Information

for the Period Ended 31 March 2023




Director: Rupert Holms
Secretary: Rupert Holms
Registered office: 71-75
Shelton Street
Covent Garden
London
GBR
WC2H 9JQ
Company Registration Number: 03340737 (England and Wales)

MEDEZRIN LTD.

Directors' Report Period Ended 31 March 2023

The directors present their report with the financial statements of the company for the period ended 31 March 2023

Principal Activities

Scientific and business consultancy

Directors

The directors shown below have held office during the whole of the period from 01 April 2022 to 31 March 2023
Rupert Holms

Secretary
Rupert Holms

This report was approved by the board of directors on 1 December 2023
And Signed On Behalf Of The Board By:

Name: Rupert Holms
Status: Director

MEDEZRIN LTD.

Profit and Loss Account

for the Period Ended 31 March 2023


Notes

2023
£

2022
£
Turnover 49,800 209,977
Cost of sales ( 43,879 ) ( 135,031 )
Gross Profit or (Loss) 5,921 74,946
Income from coronavirus (COVID-19) business support grants 0 0
Distribution Costs ( 0 ) ( 0 )
Administrative Expenses ( 36,113 ) ( 62,204 )
Other operating income 0 0
Operating Profit or (Loss) ( 30,192 ) 12,742
Interest Receivable and Similar Income 0 0
Interest Payable and Similar Charges ( 155 ) ( 16,591 )
Profit or (Loss) Before Tax ( 30,347 ) ( 3,849 )
Tax on Profit ( 0 ) ( 0 )
Profit or (Loss) for Period ( 30,347 ) ( 3,849 )

The notes form part of these financial statements

MEDEZRIN LTD.

Balance sheet

As at 31 March 2023


Notes

2023
£

2022
£
Fixed assets
Intangible assets: 4 0 0
Tangible assets: 5 1,569 1,743
Total fixed assets: 1,569 1,743
Current assets
Stocks: 0 0
Debtors: 6 0 0
Cash at bank and in hand: 1,610 31,109
Total current assets: 1,610 31,109
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 7 ( 1,089,437 ) ( 1,088,762 )
Net current assets (liabilities): ( 1,087,827 ) ( 1,057,653 )
Total assets less current liabilities: ( 1,086,258 ) ( 1,055,910 )
Creditors: amounts falling due after more than one year: 8 ( 307,514 ) ( 307,515 )
Total net assets (liabilities): ( 1,393,772 ) ( 1,363,425 )

The notes form part of these financial statements

MEDEZRIN LTD.

Balance sheet continued

As at 31 March 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 914 914
Revaluation reserve: 9 1,578,436 1,578,436
Profit and loss account: ( 2,973,122 ) ( 2,942,775 )
Shareholders funds: ( 1,393,772 ) ( 1,363,425 )

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 1 December 2023
And Signed On Behalf Of The Board By:

Name: Rupert Holms
Status: Director

The notes form part of these financial statements

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared under the historical cost convention, and in accordance with applicable accounting standards

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 0 0

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

  • 3. Off balance sheet disclosure

    No

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Intangible assets

Other Total
Cost £ £
At 01 April 2022 0 0
Additions 0 0
Disposals ( 0 ) ( 0 )
Revaluations 0 0
Transfers 0 0
At 31 March 2023 0 0
Amortisation
Amortisation at 01 April 2022 0 0
Charge for year 0 0
On disposals ( 0 ) ( 0 )
Other adjustments 0 0
Amortisation at 31 March 2023 0 0
Net book value
Net book value at 31 March 2023 0 0
Net book value at 31 March 2022 0 0

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

5. Tangible assets

Office equipment Total
Cost £ £
At 01 April 2022 1,743 1,743
Additions 0 0
Disposals ( 0 ) ( 0 )
Revaluations 0 0
Transfers 0 0
At 31 March 2023 1,743 1,743
Depreciation
At 01 April 2022 0 0
Charge for year 174 174
On disposals ( 0 ) ( 0 )
Other adjustments 0 0
At 31 March 2023 174 174
Net book value
At 31 March 2023 1,569 1,569
At 31 March 2022 1,743 1,743

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

6. Debtors


2023
£

2022
£
Trade debtors 0 0
Prepayments and accrued income 0 0
Other debtors 0 0
Total 0 0
Debtors due after more than one year: 0 0

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

7.Creditors: amounts falling due within one year note


2023
£

2022
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 0 0
Other creditors 1,089,437 1,088,762
Total 1,089,437 1,088,762

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

8.Creditors: amounts falling due after more than one year


2023
£

2022
£
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Other creditors 307,514 307,515
Total 307,514 307,515

MEDEZRIN LTD.

Notes to the Financial Statements

for the Period Ended 31 March 2023

9. Revaluation reserve


2023
£
Balance at 01 April 2022 1,578,436
Surplus or deficit after revaluation 0
Balance at 31 March 2023 1,578,436